Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death - Concepedia

Concepedia

Publication | Open Access

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death

DOI Full Paper Access

22

Citations

46

References

2015

Year

Hirokazu Sugimoto, Mizuyo Nakamura, Hiroyuki Yoda, Kiriko Hiraoka, Ken‐ichi Shinohara, Meijie Sang, Kyoko Fujiwara, Osamu Shimozato, Hiroki Nagase, Toshinori Ozaki

Cell Death Discovery

References

	Year	Citations

Page 1